ASX - By Stock
|
HUM |
Re:
Ann: Appendix 4E and FY24 Annual Report
|
|
grimloq
|
8 |
1.8K |
1 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
8
|
1.8K
|
1
|
|
ASX - By Stock
|
HUM |
Re:
Deal with MA Financial Group worth a rerate
|
|
grimloq
|
8 |
2.3K |
1 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
8
|
2.3K
|
1
|
|
ASX - By Stock
|
HUM |
Deal with MA Financial Group worth a rerate
|
|
grimloq
|
8 |
2.3K |
11 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
8
|
2.3K
|
11
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
1 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
471
|
219K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
9 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
471
|
219K
|
9
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
3 |
18/08/24 |
18/08/24 |
ASX - By Stock
|
471
|
219K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
9 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
471
|
219K
|
9
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
7 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
471
|
219K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
1 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
471
|
219K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
7 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
471
|
219K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Visual Improvement in Multiple RP11 Patients
|
|
grimloq
|
27 |
9.2K |
7 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
27
|
9.2K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
5 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
471
|
219K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Clinical Trial Update - Amended
|
|
grimloq
|
23 |
7.3K |
4 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
23
|
7.3K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Clinical Trial Update - Amended
|
|
grimloq
|
23 |
7.3K |
3 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
23
|
7.3K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Clinical Trial Update
|
|
grimloq
|
30 |
11K |
0 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
30
|
11K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Clinical Trial Update
|
|
grimloq
|
30 |
11K |
2 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
30
|
11K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Clinical Trial Update
|
|
grimloq
|
30 |
11K |
8 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
30
|
11K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Clinical Trial Update - Amended
|
|
grimloq
|
23 |
7.3K |
0 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
23
|
7.3K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
6 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
471
|
219K
|
6
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
grimloq
|
55 |
21K |
2 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
55
|
21K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
grimloq
|
55 |
21K |
2 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
55
|
21K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
grimloq
|
55 |
21K |
9 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
55
|
21K
|
9
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
grimloq
|
55 |
21K |
1 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
55
|
21K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
8 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
471
|
219K
|
8
|
|
ASX - By Stock
|
ATG |
Re:
Ann: Notification of buy-back - ATG
|
|
grimloq
|
5 |
2.5K |
2 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
5
|
2.5K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PMS Drug Candidate Effective In Human Brain Cells
|
|
grimloq
|
30 |
10K |
1 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
30
|
10K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Pyc achieved protein-restoration on genetic condition PMS ahead of human trialling
|
|
grimloq
|
1 |
606 |
3 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
1
|
606
|
3
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
0 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
471
|
219K
|
0
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
grimloq
|
172 |
80K |
5 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
172
|
80K
|
5
|
|
ASX - By Stock
|
OBL |
Re:
Ann: CBA Class Action Judgment
|
|
grimloq
|
23 |
14K |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
23
|
14K
|
3
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Trading Halt
|
|
grimloq
|
8 |
3.7K |
3 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
8
|
3.7K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q2 2024 Investor Webinar Presentation
|
|
grimloq
|
23 |
7.4K |
5 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
23
|
7.4K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q2 2024 Investor Webinar Presentation
|
|
grimloq
|
23 |
7.4K |
8 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
23
|
7.4K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Presentation of RP11 Clinical Trial Data at ARVO Conference
|
|
grimloq
|
9 |
4.3K |
6 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
9
|
4.3K
|
6
|
|
ASX - By Stock
|
HUM |
Re:
Fintech provider BidFin acquired by humm
|
|
grimloq
|
3 |
2.4K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
3
|
2.4K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
471
|
219K
|
0
|
|
ASX - By Stock
|
ATG |
Re:
Ann: 1HFY24 Investor Presentation
|
|
grimloq
|
19 |
13K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
19
|
13K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
3 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
471
|
219K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PYC Equity Raising to Raise up to $74.6 Million
|
|
grimloq
|
19 |
9.8K |
10 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
19
|
9.8K
|
10
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
0 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
471
|
219K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
0 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
471
|
219K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Half Yearly Report and Accounts
|
|
grimloq
|
8 |
3.7K |
3 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
8
|
3.7K
|
3
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Half Year Accounts
|
|
grimloq
|
6 |
2.7K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
6
|
2.7K
|
0
|
|
ASX - By Stock
|
HUM |
Re:
Ann: 1H24 Results Announcement
|
|
grimloq
|
71 |
29K |
3 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
71
|
29K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q1 2024 Investor Webinar Presentation
|
|
grimloq
|
10 |
4.8K |
1 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
10
|
4.8K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
471 |
219K |
10 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
471
|
219K
|
10
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Investment Portfolio Report at 31 December 2023
|
|
grimloq
|
4 |
1.9K |
3 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
4
|
1.9K
|
3
|
|
ASX - By Stock
|
HUM |
Re:
Ann: Update - Notification of buy-back - HUM
|
|
grimloq
|
98 |
31K |
8 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
98
|
31K
|
8
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
grimloq
|
172 |
80K |
4 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
172
|
80K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
Ann: AI Driven Drug Discovery Collaboration with Google Cloud
|
|
grimloq
|
42 |
20K |
7 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
42
|
20K
|
7
|
|